Broad-Spectrum Antiviral Drugs for Coronaviruses

Broad-Spectrum Antiviral Drugs for Coronaviruses

(From Potential Antiviral Agents for Coronavirus-es: Compounds, Herbal Products, and Drug Targets)

  • Broad-spectrum antiviral drugs may lower the vulnerability of public health systems to the coronavirus pandemic.
  • Broad-spectrum antiviral drugs are needed to
    • Combat the emergence of novel coronaviruses, e.g., COVID-19;
    • Prevent the re-emergence of SARS-CoV, its mutants, and other related viruses;
    • Combat the continuance of MERS-CoV infections (Totura and Bavari, 2019).
  • Experiences from SARS and MERS outbreaks have revealed the demands for drugs with pan-coronavirus antiviral activities.

Antiviral Strategies for Coronaviruses

(From Potential Antiviral Agents for Coronavirus-es: Compounds, Herbal Products, and Drug Targets)

  • Nucleoside analogues may have antiviral effects against SARS-CoV (Chu et al., 2006).
  • Methods can be developed to antagonize viral nonstructural proteins (Totura and Bavari, 2019).
  • Agents can be designed to neutralize structural proteins of the coronaviruses.
  • Approaches can be developed to modulate essential host elements of viral infections.

References:

Chu, C. K., Gadthula, S., Chen, X., Choo, H., Olgen, S., Barnard, D. L., & Sidwell, R. W. (2006). Antiviral activity of nucleoside analogues against SARS-coronavirus (SARS-coV). Antiviral Chemistry & Chemotherapy, 17(5), 285–289. https://doi.org/10.1177/095632020601700506

Totura, A. L., & Bavari, S. (2019). Broad-spectrum coronavirus antiviral drug discovery. Expert Opinion on Drug Discovery, 14(4), 397–412. https://doi.org/10.1080/17460441.2019.1581171

This entry was posted in Immune, Infectious Diseases, Systems Medicine and tagged , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply